Vanguard Personalized Indexing Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 5,075 shares of APLS stock, worth $192,748. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,075
Previous 4,695
8.09%
Holding current value
$192,748
Previous $281,000
6.05%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding APLS
# of Institutions
336Shares Held
109MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$572 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$431 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$422 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$361 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$209 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.17B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...